Vol. 180, Issue 13, 3470-3473, July 1, 1998
Department of Biochemistry, Mount Sinai School of Medicine of the City University of New York, New York, New York 10029
| |
ABSTRACT |
|---|
|
|
|---|
A Bacillus subtilis strain with the polynucleotide phosphorylase gene deleted was sensitive for growth in the presence of tetracycline. This strain was used to select for tetracycline-resistant mutants. A point mutation in the tetA(L) promoter and a spontaneously occurring tetA(L) gene copy number mutant were characterized.
| |
ARTICLE |
|---|
|
|
|---|
The tetA(L) gene of Bacillus subtilis Marburg 168 strains confers low-level resistance to tetracycline (TET). This gene was identified by Williams and Smith (17), who isolated mutants of B. subtilis that were able to grow on 50 µg of TET/ml. Sakaguchi and Shishido (15) cloned this gene and showed that its presence on a plasmid conferred inducible TET resistance on B. subtilis. The tetA(L) gene normally confers resistance to concentrations of TET up to 2 µg/ml. Upon protoplast regeneration (10, 18) or transformation with a tetA(L)-containing plasmid (9), amplification of the chromosomal tetA(L) locus can occur, resulting in significantly elevated levels of TET resistance. Krulwich and colleagues demonstrated that the tetA(L) gene product functions as a TET-metal/H+ antiporter and as a physiologically significant Na+/H+ antiporter (3, 5). By using tetA(L)-lacZ fusion strains, it was demonstrated that expression of tetA(L) was induced 25-fold in the presence of 0.25 µg of TET/ml (4). The tetA(L) leader region, which contains a ribosome binding site and a short open reading frame (Fig. 1B), is thought to be involved in the regulation of tetA(L) expression. Northern blot analysis showed a two- to threefold increase in tetA(L) mRNA in response to inducing concentrations of TET. Reverse transcriptase analysis of tetA(L) mRNA indicated two transcriptional start sites 5 nucleotides apart (Fig. 1C).
|
Polynucleotide phosphorylase (PNPase), encoded by the pnpA gene (11, 12), is a 3'-to-5' exoribonuclease thought to be involved in mRNA decay. We constructed a pnpA deletion strain, designated BG119, and found that this strain was more sensitive to TET than the wild type (16). In this study, BG119 was tested quantitatively for sensitivity to TET. The growth of BG119 was severely compromised in 0.8 µg of TET/ml and was completely inhibited in 1.0 µg of TET/ml (data not shown). The wild-type B. subtilis strain, on the other hand, grew well in concentrations of TET up to 2 µg/ml (see Fig. 2). We took advantage of the TET sensitivity of the pnpA deletion strain to select for TET-resistant mutants. (All strains used in this study are listed in Table 1.)
|
To map mutations in BG119 relative to the tetA(L) locus, a
spectinomycin resistance gene, cloned as an EcoRI fragment,
was inserted into the chromosome at the MunI site, located
1.65 kb upstream of the tetA(L) gene (Fig. 1A), producing
strain BG161. Cultures of BG161 were grown overnight, and aliquots were
plated on solid medium containing 3 µg of TET/ml. After overnight
growth at 37°C, TET-resistant colonies arose at a frequency of about 10
8.
The Tcr colonies were mostly small (1 mm in diameter or smaller), but several larger colonies were obtained. The growth of one large colony and two smaller colonies, in the presence of TET, is shown in Fig. 2. The least-resistant strains (represented by BG182) could grow in the presence of 2 µg of TET/ml, which was similar to the level of TET resistance of the wild type (BG1). The mutations in these strains were unlinked to the tetA(L) locus, and they were not characterized further. A second class of mutants (represented by BG179) was able to grow well in 6 µg of TET/ml but grew poorly at 8 µg/ml. In two of these, designated BG178 and BG179, the mutations that conferred TET resistance were found to be 60 to 70% linked to the Spr marker. Sequence analysis showed that these strains contained only the wild-type tetA(L) gene. By Southern blot analysis, it was determined that these strains had a fourfold amplification of the tetA(L) locus (data not shown).
|
The single large colony that was picked (BG162) represented the third
class, for which reasonable growth was observed in 8 µg of TET/ml
(Fig. 2). The mutation in BG162 was more than 90% linked to the
Spr marker. Sequencing of the tetA(L) promoter
in BG162 revealed an A
G change in the
10 sequence for the upstream
start site (
10a) (Fig. 1C). The same A
G change was found in a
large Tcr colony from a second plating experiment.
The transcriptional start site for tetA(L) mRNA was examined
by reverse transcriptase analysis (Fig.
3A). The amount of tetA(L) mRNA from the mutant strain (BG162) was approximately 10-fold greater
than that from the wild-type strain (BG1). In both the wild-type and
mutant strains, the level of transcriptional induction by TET was about
twofold. Strikingly, the minor downstream transcriptional start site of
the wild-type tetA(L) (+1b) was the sole transcriptional start site in BG162. Examination of the promoter sequence (Fig. 1C)
shows that this change created a TG dinucleotide at the
15 and
14
positions relative to the downstream start site. This
15,
14
sequence is highly conserved among B. subtilis promoter sequences (7) and has been found to exert a strong positive effect on transcription by B. subtilis RNA polymerase
(8).
|
To demonstrate that the A
G change was the only mutation necessary
for the increase in tetA(L) transcription, and to quantitate the effect of the mutation on tetA(L) expression,
tetA(L)-lacZ fusions containing either wild-type
or mutant promoter regions were constructed at the amyE
locus of BD99. Uninduced and induced
-galactosidase levels were
seven- to eightfold higher in the mutant than in the wild type.
However, the levels of induction of tetA(L) expression in
the presence of TET were similar for wild-type and mutant
tetA(L)-lacZ strains: 16- and 21-fold,
respectively.
To demonstrate that the changes in tetA(L) transcription
were due solely to the cis-acting effect of the A
G point
mutation and were not dependent on a trans-acting factor, a
260-bp EcoRI-XbaI fragment containing the
tetA(L) promoter and leader region was cloned from wild-type
and mutant tetA(L) genes into the transcription vector
plasmid pAN583 (14). This plasmid contains a transcriptional terminator sequence downstream of a multicloning site. Transcription was performed on supercoiled DNA or on DNA that had been linearized with XbaI or with HindIII; the
HindIII site in the vector is located 25 bp downstream
of the XbaI site. Transcription reaction mixtures contained
40 mM Tris (pH 7.9), 50 mM NaCl, 10 mM MgCl2, 1 mM each of
the four nucleoside triphosphates, 8 µM
-mercaptoethanol, 10 µCi
of [
-32P]UTP, and 0.5 µg of linearized or
supercoiled plasmid DNA. The reaction was started by the addition of 5 µg of B. subtilis RNA polymerase holoenzyme. After
incubation at 37°C for 25 min, 1 µl of a 6-mg/ml solution of
heparin was added, and the incubation was continued at 37°C for 5 min. After DNase treatment for 15 min, the reaction product was
extracted with phenol-chloroform (1:1), and nucleic acid was
precipitated. Reaction products were separated on a 6% denaturing
polyacrylamide gel. Transcription using the mutant template gave a
fourfold-higher amount of RNA than transcription using the wild-type
template (Fig. 3B, lanes A and C). It was further evident from the
results in Fig. 3B that the transcription start sites differed for the
mutant and wild-type templates. This was confirmed by reverse
transcriptase analysis of in vitro-transcribed tetA(L) RNA
(Fig. 3C). The +1a nucleotide was the major start site for
transcription in the wild type, while the +1b nucleotide was the
exclusive start site for the mutant. We conclude that the change in the
level of transcription and the start site choice in BG162 are
determined solely by the point mutation.
BG162 was able to grow well in 8 µg of TET/ml, which was four times
the highest level of TET in which the wild-type BG1 strain could grow.
However, the BG162 strain also contains the pnpA deletion, which we have shown causes an increase in TET accumulation
(16). To test the level of resistance conferred by the A
G
change on wild-type B. subtilis, the mutation was
transferred to BG1 to produce strain BG226. BG226 was able to grow well
at TET concentrations up to 20 µg/ml, which was the challenge
concentration used in previous studies (10, 18).
Unlike the findings of the previous work, in which a protoplast regeneration regimen or transformation with a plasmid carrying the tetA(L) gene was required to obtain highly amplified tetA(L) regions, we isolated strains with a fourfold amplification of the tetA(L) locus without prior manipulations. Although the tetA(L) gene is flanked by three highly homologous copies of a small (170-bp) direct repeat sequence (Fig. 1A) (1), it is unlikely that these elements are involved in the duplication. From additional Southern blot analyses, we found that the amplified units in BG178 and BG179 were larger than the segments between these repeat sequences.
We note that Hashiguchi et al. (6) have reported endogenous chromosomal amplification in B. subtilis, in cells treated with a chemical mutagen, which resulted in tunicamycin resistance. Also, Neyfakh et al. (13) have characterized a B. subtilis strain with an amplified bmr gene, but this was isolated after growth for several weeks in the presence of increasing drug concentrations.
The shift in transcription start site that resulted from the A
G
mutation did not appear to affect the expression of tetA(L). In other studies (15a), we have found that
tetA(L) expression is regulated at the transcriptional,
posttranscriptional, and translational levels. The existence of two
transcriptional start sites adds another level of complexity. Multiple
controls on tetA(L) gene expression imply that the level of
TetA(L) protein must be precisely regulated, which supports earlier
evidence that tetA(L) plays a major role in B. subtilis pH homeostasis and monovalent cation efflux (3,
4).
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Public Health Service grant GM-52837.
We thank I. Smith for providing B. subtilis RNA polymerase holoenzyme and K. Hue-Roye for technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Biochemistry, Mount Sinai School of Medicine of the City University of New York, New York, NY 10029. Phone: (212) 241-5628. Fax: (212) 996-7214. E-mail: dbechho{at}smtplink.mssm.edu.
| |
REFERENCES |
|---|
|
|
|---|
A-dependent promoter sequences: evidence for extended contact between RNA polymerase and upstream promoter DNA.
Nucleic Acids Res.
13,
2351-2360.
H.
J. Bacteriol.
174,
2771-2778This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |